Blue Cross Blue Shield of Mississippi
site map

About Us   Careers    Site Map

  • Be Healthy
  • I'm a Member
  • I'm a Provider
  • I'm an Employer
  • Find Coverage

I'm a member

You will be redirected to myBlue. Would you like to continue?

please waitPlease wait while you are redirected.

myBlue member login

 Username:
 Password:
  • Forgot Username »
  • Forgot Password »
  • Learn more about myBlue »

Find a Network Provider

be RxSmart

Community PLUS Pharmacy
     Search

State & School Health Plan

Federal Employee Program

Member Links

Healthy You! Wellness Benefit »

Pay by Bank Draft »

View Our Medical Policy »

Military Benefit Information »

Register for myBlue »

Fight Fraud »


Contact Us
Customer Service Team
601-664-4590 or 1-800-942-0278

General Information
601-932-3704

Medical Policy Search



Printer Friendly Version Hyperbaric Oxygen (HBO) Pressurization

Hyperbaric Oxygen (HBO) Pressurization

 

DESCRIPTION

Hyperbaric oxygen therapy (HBO2) is a technique of delivering higher pressures of oxygen to the tissues. Two methods of administration are available. In systemic or large chamber hyperbaric oxygen, the patient is entirely enclosed in a pressure chamber and breathes oxygen at a pressure greater than one atmosphere (the pressure of O2 at sea level). Thus this technique relies on the systemic circulation to deliver highly oxygenated blood to the target site, typically a wound. In addition, systemic hyperbaric oxygen therapy can be used to treat systemic illness such as air or gas embolism, carbon monoxide poisoning, clostridial gas gangrene, etc. Treatment may be carried out either in a monoplace chamber pressurized with pure oxygen or in a larger, multiplace chamber pressurized with compressed air, in which case the patient receives pure oxygen by mask, head tent, or endotracheal tube.

Topical hyperbaric oxygen therapy is a technique of delivering 100% oxygen directly to an open, moist wound at a pressure slightly higher than atmospheric pressure. It is hypothesized that the high concentrations of oxygen diffuse directly into the wound to increase the local cellular oxygen tension, which in turn promotes wound healing. Topical hyperbaric oxygen devices consist of an appliance to enclose the wound area (frequently an extremity) and a source of oxygen; conventional oxygen tanks may be used. The appliances may be disposable and may be used without supervision in the home by well-trained patients. Topical hyperbaric oxygen therapy has been investigated as a treatment of skin ulcerations due to diabetes, venous stasis, postsurgical infection, gangrenous lesions, decubitus ulcers, amputations, skin grafts, burns, or frostbite.

 

POLICY

I. Topical hyperbaric oxygen therapy is considered investigational.

II. Systemic hyperbaric oxygen pressurization may be considered medically necessary in the treatment of the following conditions:

  • Non-healing diabetic wounds of the lower extremities in patients who meet all of the following 3 criteria:
  1. Patient has type I or type II diabetes and has a lower extremity wound that is due to diabetes, and
  2. Patient has a wound classified as Wagner grade 3 or higher*; and
  3. Patient has no measurable signs of healing after 30 days of an adequate course of standard wound therapy
  • Acute traumatic ischemia (e.g., crush injury, reperfusion injury, compartment syndrome)
  • Decompression sickness
  • Gas embolism, acute
  • Cyanide poisoning, acute
  • Soft-tissue radiation necrosis (e.g., radiation enteritis, cystitis, proctitis) and osteoradionecrosis
  • Pre- and post-treatment for patients undergoing dental surgery (non-implant related) of an irradiated jaw
  • Gas gangrene (i.e., clostridial myonecrosis)
  • Profound anemia with exceptional blood loss only when blood transfusion is impossible or must be delayed, or when loss can be due to homolysis exsanguination
  • Acute carbon monoxide poisoning
  • Chronic refractory osteomyelitis

* The Wagner classification system of wounds is defined as follows:

Grade 0

No open lesion

Grade 1

Superficial ulcer without penetration to deeper layers

Grade 2

Ulcer penetrates to tendon, bone, or joint

Grade 3

Lesion has penetrated deeper than grade 2 and there is abscess, osteomyelitis, pyarthrosis, plantar space abscess, or infection of the tendon and tendon sheaths

Grade 4

Wet or dry gangrene in the toes or forefoot

Grade 5

Gangrene involves the whole foot or such a percentage that no local procedures are possible and amputation (at least at the below the knee level) is indicated

III. Hyperbaric oxygen pressurization is considered investigational in the treatment of the following conditions:

  • Compromised skin grafts or flaps
  • Acute osteomyelitis, refractory to standard medical management
  • Necrotizing soft-tissue infections
  • Acute thermal burns
  • Acute surgical and traumatic wounds
  • Chronic wounds, other than those in patients with diabetes who meet the criteria specified in the medically necessary statement
  • Spinal cord injury
  • Traumatic brain injury
  • Severe or refractory Crohn’s disease
  • Brown recluse spider bites
  • Bone grafts
  • Carbon tetrachloride poisoning, acute
  • Cerebrovascular disease, acute (thrombotic or embolic) or chronic
  • Fracture healing
  • Hydrogen sulfide poisoning
  • Intra-abdominal and intracranial abscesses
  • Lepromatous leprosy
  • Meningitis
  • Pseudomembranous colitis (antimicrobial agent-induced colitis)
  • Radiation myelitis
  • Sickle cell crisis and/or hematuria
  • Demyelinating diseases, e.g., multiple sclerosis, amyotrophic lateral sclerosis
  • Retinal artery insufficiency, acute
  • Retinopathy, adjunct to scleral buckling procedures in patients with sickle cell peripheral retinopathy and retinal detachment
  • Pyoderma gangrenosum
  • Acute arterial peripheral insufficiency
  • Acute coronary syndromes and as an adjunct to coronary interventions, including but not limited to percutaneous coronary interventions and cardiopulmonary bypass
  • Idiopathic sudden sensorineural hearing loss
  • Refractory mycoses: mucormycosis, actinomycosis, canidiobolus coronato
  • Cerebral edema, acute
  • Migraine
  • Invitro fertilization
  • Cerebral palsy
  • Tumor sensitization for cancer treatments, including but not limited to, radiotherapy or chemotherapy
  • Delayed onset muscle soreness
  • Idiopathic femoral neck necrosis
  • Chronic arm lymphedema following radiotherapy for cancer
  • Radiation-induced injury in the head and neck
  • Early treatment (beginning at completion of radiation therapy) to reduce adverse effects of radiation therapy
  • Autism spectrum disorders
  • Acute ischemic stroke
  • Bell’s palsy

The following criteria taken from The Undersea and Hyperbaric Medical Society’s 1996 Hyperbaric Oxygen Therapy Committee may be used as a guideline for Systemic Hyperbaric Oxygen utilization:

Gas gangrene

10 treatments

Acute traumatic ischemia

As Follows:

  • 3 treatments per day for 48 hours, followed by
  • 2 treatments per day over the second 48 hours, and
  • 1 treatment per day over the third period of 48 hours.
  • Beyond this time period, utilization review should be obtained.

Decompression sickness

Treatment times vary; depending on length of time elapsed between symptoms and initiation of treatment and between residual symptoms after initial treatment.

Usual time between treatments ranges from 1.5 to 14.0 hours.

Repetitive treatments may be necessary, depending on the patient’s response.

Exceptional blood loss anemia

For class IV hemorrhage, HBO2 is indicated when the patient will not accept blood replacement for medical or religious reasons and all of the following symptoms are present:

  • Shock, systolic blood pressure below 90 mm Hg, or pressure maintained by vasopressors, and
  • Disorientation to coma, and
  • Ischemic changes of the myocardium as demonstrated on the electrocardiogram (EKG), and 
  • Ischemic gut

HBO2 therapy is continued as needed and discontinued when the red blood cells have been replaced in numbers to alleviate the preceding signs and symptoms.

Radiation necrosis

Treatments are usually given daily for 90 to120 minutes.

Utilization review is required after 60 treatments.

Coverage:

  • All medically necessary indications will be allowed for the first 20 treatments
  • Coverage for additional benefits beyond this will only be allowed if there is written documentation in the patient's chart of wound healing and improvement (e.g., new tissue growth, shrinkage of ulcer, etc.)
  • Reassessments and written documentation of continued wound healing must be done, at a minimum, every two (2) weeks
  • Benefits will not be provided beyond a 3 month period

 

POLICY EXCEPTIONS

Federal Employee Program (FEP) may dictate that all FDA-approved devices, drugs or biologics may not be considered investigational and thus these devices may be assessed only on the basis of their medical  necessity.

 

POLICY GUIDELINES

Investigative service is defined as the use of any treatment procedure, facility, equipment, drug, device, or supply not yet recognized by certifying boards and/or approving or licensing agencies or published peer review criteria as standard, effective medical practice for the treatment of the condition being treated and as such therefore is not considered medically necessary.

As specified in CPT code 99183, physician attendance and supervision of hyperbaric oxygen therapy is required.

The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language.

 

POLICY HISTORY

3/1993: Approved by Medical Policy Advisory Committee (MPAC)

2/1997: Revision approved by MPAC. Thermal Burns, necrotic wounds to brown recluse spider bite and multiple sclerosis moved to investigational status. Required documentation after twenty (20) treatment limit and three (3) month maximum added.

5/2000: Revision approved by MPAC; soft tissue infections moved to investigational status and topical HBO2 added to investigational status. Undersea and Hyperbaric Medical Society's HBO therapy utilization guidelines added.

1/29/2001: HCPCS G0167 added covered codes

1/23/2002: Prior authorization deleted

2/7/2002: Investigational definition added

5/1/2002: Type of Service and Place of Service deleted

5/28/2002: Code Reference section updated, ICD-9 diagnosis code 784.5 should be 785.4, ICD-9 diagnosis code 383.20, 447.8, 454.0, 454.2, 459.89 added covered codes, ICD-9 diagnosis code 707.10, 707.11, 707.12, 707.13, 707.14, 707.15, 707.19, 707.8, 707.9 added non-covered codes, HCPCS A4575, A4619, E1390, E1391, E1399, E1405, E1406 added covered codes

9/20/2002: Policy reviewed, Hayes report number added

11/11/2002: HCPCS A4575 moved from covered codes to non-covered codes, Hayes report number deleted

3/10/2004: Code Reference section updated, invalid ICD-9 diagnosis code 929.99 deleted covered codes, ICD-9 diagnosis code 707.10, 707.11, 707.12, 707.13, 707.14, 707.15, 707.19, 707.8, 707.9 moved from non-covered codes to covered codes

11/5/2004: Code Reference section updated, ICD-9 procedure code 93.59 added non-covered codes, ICD-9 diagnosis code 006.5, 013.30, 013.31, 013.32, 013.33, 013.34, 013.35, 013.36, 030.0, 282.62, 320.0, 320.1, 320.2, 320.3, 320.7, 320.81, 320.82, 320.89, 320.9, 321.0, 321.1, 321.2, 321.3, 321.4, 321.8, 322.0, 322.1, 322.2, 322.9, 323.9, 324.0, 324.9, 326, 340, 361.00, 361.01, 361.02, 361.03, 361.04, 361.05, 361.06, 361.07, 361.2, 361.81, 361.89, 361.9, 362.60, 362.61, 362.62, 362.63, 362.64, 362.65, 362.66, 435.8, 436, 540.1, 556.2, 558.9, 569.5, 569.61, 572.0, 590.2, 599.7, 686.00, 686.01, 686.09, 776.5, 777.5, 800.00-800.99, 801.00-801.99, 802.0-802.9, 803.00-803.99, 804.00-804.99, 850.0-850.9, 851.00-851.99, 852.00-852.59, 853.00-853.19, 854.00-854.19, 940.0-940.9, 941.00-941.09, 941.10-941.19, 941.20-941.29, 941.30-941.39, 941.40-941.49, 941.50-941.59, 942.00-942.09, 942.10-942.19, 942.20-942.29, 942.30-942.39, 942.40-942.49, 942.50-942.59, 943.00-943.09, 943.10-943.19, 943.20-943.29, 943.30-943.39, 943.40-943.49, 943.50-943.59, 944.00-944.08, 944.10-944.18, 944.20-944.28, 944.30-944.38, 944.40-944.48, 944.50-944.58, 945.00-945.09, 945.10-945.19, 945.20-945.29, 945.30-945.39, 945.40-945.49, 945.50-945.59, 946.0-946.5, 947.0-947.9, 948.00-948.99, 949.0-949.5, 952.00-952.9, 959.01, 982.1, 985.1, 996.4, V12.59 deleted non-covered codes, HCPCS G0167 deletion date of 12/31/2004 added

9/19/2005: ICD-9 procedure code 93.59 moved from non-covered to covered codes

5/24/2006: G0167 deleted 12-31-2003. Code removed from the covered table

9/12/2006:  Coding updated.  CPT4/HCPCS 2006 revisions added to policy

11/29/2006: The following are now listed as investigational : amyotrophic lateral sclerosis; compromised skin grafts or flaps; chronic refractory osteomyelitis and acute osteomyelitis, refractory to standard medical management; delayed onset muscle soreness; acute cerebral edema; refractory mycoses: mucormycosis, actinomycosis, canidiobolus coronato; radiation necrosis (osteoradionecrosis and soft tissue radiation necrosis); acute arterial peripheral insufficiency; acute coronary syndromes and as an adjunct to coronary interventions, including but not limited to percutaneous coronary interventions and cardiopulmonary bypass; idiopathic sudden sensorneural hearing loss; migraine; in vitro fertilization; cerebral palsy; tumor sensitization for cancer treatments, including but not limited to, radiotherapy or chemotherapy. Removed "Radiation necrosis - utilization review is required after 60 treatments. Treatments are usually given daily for 90 to 120 minutes" from policy section

11/30/2006: Code Reference section updated. Deleted the following ICD-9 codes: 039.0-039.9, 090.0, 095.5, 111.0-111.9, 112.0, 112.1, 112.2, 112.3, 117.9, 348.5, 376.03, 383.20, 526.5, 526.89, 682.0-682.9, 686.00-686.09, 686.1, 686.8, 686.9, 730.00-730.29, 730.80-730.89, 767.8, 990, 996.52, and 996.79

3/19/2008: Soft tissue radiation necrosis and osteoradionecrosis changed from investigational to medically necessary. Added pre- and post treatment for dental surgery of an irradiated jaw may be considered medically necessary. Code reference section updated; ICD-9 codes 526.89, 909.2, and 909 added to covered table.

7/17/2008: Reviewed and approved by MPAC

9/17/2008: Annual ICD-9 updates effective 10-1-2008 applied

12/1/2009: Policy Statement Section revised as follows: Hyperbaric oxygen pressurization is now not medically necessary for the treatment of acute carbon monoxide poisoning. Venous stasis ulcers and arterial insufficiency ulcers removed from medically necassary conditions. Additional criteria and Wagner classification system of wounds added to medically necessary criteria for non-healing diabetic wounds. Severe or refactory Crohn's disease added to investigational criteria. The Undersea and Hyperbaric Medical Society guideline updated with radiation necrosis information. Policy Exceptions Section revised to include FEP verbiage. Policy Coding Section revised as follows: ICD9 diagnosis codes 447.8, 454.0, 454.2, 459.89, 707.8, 707.9 removed from Covered Codes Table. ICD9 diagnosis code 986 moved to Non-Covered Codes Table, ICD9 Diagnosis Code 040.42 added to Covered Codes Table. HCPCS codes A4619, A4620, E0455, E1390, E1399, E1405, E1406 removed from Covered Codes Table.

09/09/2010:  Policy statement revised to indicate that HBO for acute carbon monoxide poisioning and chronic refractory osteomyelitis may be considered medically necessary. Added ICD-9 codes 730.00-730.19 to the Covered Codes table.  Moved ICD-9 code 986 from non-covered to covered.

11/10/2011:  Add the following as investigational indications for HBO:  acute surgical and traumatic wounds, idiopathic femoral neck necrosis, chronic arm lymphedema following radiotherapy for cancer, radiation-induced injury in the head and neck, early treatment (beginning at completion of radiation therapy) to reduce adverse effects of radiation therapy, and autism spectrum disorders.

09/27/2012:  Policy statement revised to add the following indications as investigational:  acute ischemic stroke, Bell’s palsy, and chronic wounds, other than those in patients with diabetes who meet the criteria specified in the medically necessary statement. Added reperfusion injury, compartment syndrome as examples of acute traumatic ischemia.

 

SOURCE(S)

Hayes Medical Technology Directory

Blue Cross Blue Shield Association policy # 2.01.04

 

CODE REFERENCE

This is not intended to be a comprehensive list of codes. Some covered procedure codes have multiple descriptions.

The code(s) listed below are ONLY covered if the procedure is performed according to the "Policy" section of this document. 

Covered Codes

Code Number

Description

CPT-4

99183

Physician attendance and supervision of hyperbaric oxygen therapy, per session (required)

ICD-9 Procedure

93.59

Other immobilization, pressure, and attention to wound (oxygenation of wound, hyperbaric)

93.95

Hyperbaric oxygenation

ICD-9 Diagnosis

040.0, 040.42

Gas gangrene (clostridium code range)

249.70, 249.71

Secondary diabetes mellitus with peripheral circulatory disorders

249.80, 249.81

Secondary diabetes mellitus with other specified manifestations

250.70, 250.71, 250.72, 250.73,

Diabetes with peripheral circulatory disorders code range

250.80, 250.81, 250.82, 250.83

Diabetes with other specified manifestations code range

285.1

Acute post-hemorrhagic anemia

526.89

Other specified disease of the jaws

707.10, 707.11, 707.12, 707.13, 717.14, 707.15, 707.19

Ulcer of lower limb code range

730.00-730.19

Chronic osteomyelitis (Added 09-09-2010)

785.4

Gangrene

909.2

Late effect of radiation

925.1

Crushing injury of face and scalp

925.2

Crushing injury of neck

926.0

Crushing injury of external genitalia

926.11

Crushing injury of back

926.12

Crushing injury of buttock

926.19

Crushing injury of other specified sites of trunk

926.8

Crushing injury of multiple sites of trunk

926.9

Crushing injury of unspecified site of trunk

927.00, 927.01, 927.02, 927.03, 927.09

Crushing injury of upper limb code range

927.10

Crushing injury of forearm

927.11

Crushing injury of elbow

927.20

Crushing injury of hand(s)

927.21

Crushing injury of wrist

927.3

Crushing injury of finger(s)

927.8

Crushing injury of multiple sites of upper limb

927.9

Crushing injury of unspecified site of upper limb

928.00

Crushing injury of thigh

928.01

Crushing injury of hip

928.10

Crushing injury of lower leg

928.11

Crushing injury of knee

928.20

Crushing injury of foot

928.21

Crushing injury of ankle

928.3

Crushing injury of toe(s)

928.8

Crushing injury of multiple sites of lower limb

928.9

Crushing injury of unspecified site of lower limb

929.0

Crushing injury of multiple sites, not elsewhere classified

929.9

Crushing injury of unspecified site

958.0

Air embolism

986

Toxic effect of carbon monoxide (Moved to covered 09-09-2010)

989.0

Cyanide poisoning, acute

990

Effects of radiation, unspecified

993.3

Caisson disease (decompression sickness)

HCPCS

 

 


This is not an all-inclusive list of non-covered procedure codes.

The code(s) listed below and ANY code not listed in the previous section are considered non-covered for this procedure.  

Non-Covered Codes 

Code Number

Description

CPT-4

 

 

ICD-9 Procedure

 

 

ICD-9 Diagnosis

 

 

HCPCS

A4575

Topical hyperbaric oxygen chamber, disposable

 

 

 

 

 

 

 

 

 

 

 

 

 

Top




Copyright © 2007-2013, Blue Cross & Blue Shield of Mississippi, A Mutual Insurance Company. All Rights Reserved.
An independent licensee of the Blue Cross and Blue Shield Association.

About Us  ·   Careers   ·   Terms of Use  ·   Privacy Practices  ·   Accreditation  ·   Site Map